Molnupiravir, also known by its brand name MK-4488, represents a significant advancement in the effort against COVID-19. This taken by mouth antiviral compound works molnupiravir by introducing errors into the virus's genetic sequence, effectively halting its copying and progression within the individual. While initial data suggested a significant